A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2004
12/08/2004	EP1252155B1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
12/08/2004	EP1224164B1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1150694B1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1121354B1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h 3 agonists or antagonists
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	CN1553961A Membrane virus host range mutations and their uses as vaccine substrates
12/08/2004	CN1553958A Photochemical internalization for delivery of molecules into the cytosol
12/08/2004	CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1552892A Physiological active buck peptide by compound proteinase catalysis and use of products thereby
12/08/2004	CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant
12/08/2004	CN1552447A Adjuvant for improving hepatitis B vaccine immune effect and preparing method thereof
12/08/2004	CN1552445A Medicinal preparation for preventing from pyloric helicobacterium inflammation
12/08/2004	CN1552412A Prescription and use of salviae miltiorrhizae or lignum santali and salviae miltiorrhizae injection plus soluble intravenous infusion preparation
12/08/2004	CN1552324A Medicinal composition for stabilizing delotadine in preparation
12/08/2004	CN1552322A Pharmaceutical compositions of tizoxanide and nitazoxanide
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004	CN1178697C Infectious bursits vaccine
12/08/2004	CN1178690C Production method for making medicine of regulating immunity
12/08/2004	CN1178672C Process for preparing polypeptide-nucleic acid nutritive liquid of sheep placenta
12/08/2004	CN1178666C Gypenoside drip pill, and preparing process thereof
12/08/2004	CN1178656C Pharmaceutical composition
12/08/2004	CN1178653C Drug composition
12/08/2004	CN1178652C Mizoribine tablet with improved colour
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828326 Pyrimidinone fused bicyclic metalloproteinase inhibitors
12/07/2004	US6828316 Antiallergens
12/07/2004	US6828312 Therapy of mammal susceptible to, suffering from, suspected of having or recovering from a disease impacted by tissue factor(TF), by administering TF blocking compound
12/07/2004	US6827946 Compositions containing both sedative and non-sedative antihistamines
12/07/2004	US6827940 Forming nontoxic, stable, water soluble antitumor powders; heat and acid treatment of gram positive bacteria containing peptidoglycan, removing insolubles, neutralizing and lyophil-izing
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect
12/07/2004	CA2217776C Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/02/2004	WO2004104047A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them
12/02/2004	WO2004104045A1 Therapeutical use of anti-cd70 antibody for treating or preventing aids
12/02/2004	WO2004104000A1 Tricyclic condensed ring compound and medical use thereof
12/02/2004	WO2004103974A1 Substituted 2-oxoquinoline compound and medicinal use thereof
12/02/2004	WO2004103971A1 Cyclic aminophenyl sulfamate derivative
12/02/2004	WO2004103403A1 Immunocompetent cell activation inhibitor and use thereof
12/02/2004	WO2004103401A2 Avian combination-vaccine against e.coli and salmonella
12/02/2004	WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242663 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
12/02/2004	US20040242654 Diaryl ether derivative, addition salt thereof, and immunosuppressant
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242619 Processes for preparation of polymorphic forms of desloratadine
12/02/2004	US20040242613 Pyrimidine derivatives useful as inhibitors of PKC-theta
12/02/2004	US20040242598 Phosphodiesterase 4 inhibitors
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242481 Use of hmgb1 for the activation of dendritic cells
12/02/2004	US20040242477 Capable of introducing aldehyde or ketone functions into proteins in a site-specific and pharmaceutically acceptable manner
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040242455 which exerts potent and selective activated blood coagulation factor X inhibitory activity and is useful for prevention or treatment of disease associated therewith
12/02/2004	US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241745 Substance specific to pd-1
12/02/2004	US20040241310 Method of producing antibodies ex-vivo
12/02/2004	US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids
12/02/2004	US20040241232 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/02/2004	US20040241204 Sustained release pharmaceutical composition
12/02/2004	US20040241184 Fermentation product of cyptoporous volvatus and its preparation method and use
12/02/2004	US20040241178 Allergen peptide fragments and use thereof
12/02/2004	US20040241176 Method of producing membrane vesicles
12/02/2004	US20040241175 Antigen targeting
12/02/2004	US20040241171 Leukocyte inactivation module
12/02/2004	US20040241149 prevention or prophylaxis of inflammatory condition comprising administering lactic acid bacteria containing unmethylated cytosine-guanine (cpg) dinucleotide to modulate the cytokine response of human or animal immune system; antiinflammatory agents
12/02/2004	US20040241140 Expression vectors able to elicit improved immune response and methods of using same
12/02/2004	CA2528521A1 Disease prevention and vaccination prior to thymic reactivations
12/02/2004	CA2526275A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them
12/02/2004	CA2489124A1 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
12/02/2004	CA2469528A1 Peptide and peptide mimetic derivatives having integrin inhibitor properties iii
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481250A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
12/01/2004	EP1481006A2 Universal antimicrobial treatment

1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 1172